COMPANY NEWS


Natco Pharma Ltd
BSE Code 524816 ISIN Demat INE987B01026 Book Value (₹) 284.47 NSE Symbol NATCOPHARM Div & Yield % 0.54 Market Cap ( Cr.) 18,509.21 P/E * 15.28 EPS * 67.65 Face Value (₹) 2
* Profit to Earning Ratio
* Earning Per Share
Natco Pharma receives warning letter from USFDA for its Kothur unit Back
(09 Apr 2024)
Natco Pharma has received a warning letter dated 08 April 2024 from the United States Food and Drug Administration (USFDA) for its Kothur (Pharma Division) manufacturing facility. The Company does not believe that the warning letter will have an impact on disruption of supplies or existing revenues from this facility. It may cause delay/withholding of pending product approvals from this site.